Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023;16(1):125-137.
doi: 10.3233/PRM-210112.

Time-matched accelerometers on limbs and waist in children with CP give new insights into real-life activities after botulinum toxin treatment: A proof of concept study

Stefan Gantelius  1   2 , Sandra Vikerfors  1   3 , Josefin Jansson Edqvist  1 , Ferdinand von Walden  1 , Maria Hagströmer  4   5 , Eva Pontén  1   2
Affiliations
Observational Study

Time-matched accelerometers on limbs and waist in children with CP give new insights into real-life activities after botulinum toxin treatment: A proof of concept study

Stefan Gantelius et al. J Pediatr Rehabil Med. 2023.

Abstract

Purpose: This study aimed to explore the feasibility of using time-matched uniaxial accelerometers for measuring movement in daily life in children with cerebral palsy (CP) before and after botulinum toxin injections.

Methods: This observational study of clinical care with a pre-post design was set in the home and school environment. Participants included eleven children (4-13 years of age) with CP (GMFCS I-III). The children wore uniaxial accelerometers (ActiGraph, model GT1M) for 4 days on both wrists, the right ankle and around the waist before, 3 weeks and 3 months after BoNT-A injections in the legs. Five children also got BoNT-A in the most affected arm. All injections were given according to clinical indications and routine. The accelerometers were all time-matched to define ambulation, arm swing, voluntary activity of arms, and bimanual activity. The feasibility of wearing accelerometers with this setup was evaluated. A linear mixed model was used for analysis of the percentage time and at which intensity the different activities were performed. The confidence interval demonstrated any difference between the dominant and non-dominant arm.

Results: Time-matching of accelerometers placed on both wrists, the waist, and one ankle is a feasible method of registering ambulation, arm swing during gait, and arm movements while not ambulating. Before injections, the children spent 5.6% of their time ambulating. This value declined to 3.9% at 3 months. Contrary to clinical goals, arm movement did not increase after injecting the most affected arm with BoNT-A, however, injections may have decreased mirror movements, which are often bothersome for the child.

Conclusion: A time-matched 4-accelerometer set-up is feasible in children with cerebral palsy. A future study including time-matched multi-axial accelerometers on all four limbs, could provide important information on the effect of BoNT-A in daily life.

Keywords: Accelerometry; Type A; adolescent; botulinum toxins; cerebral palsy; child; extremities.

PubMed Disclaimer

Conflict of interest statement

None of the authors have declared to have a conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Himmelmann K, Uvebrant P The panorama of cerebral palsy in Sweden part XII shows that patterns changed in the birth years 2007-2010. Acta Paediatr. 2018;107(3):462–468. doi: 10.1111/apa.14147. - DOI - PubMed
    1. Gracies J-M Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve. 2005; 31(5):535–51. doi: 10.1002/mus.20284. - DOI - PubMed
    1. Lance JW Symposium synopsis. In: Feldman RG, Koella WP, Young RR, editors. Spasticity: disordered motor con trol. Chicago: Year Book Medical Publishers; 1980;. p. 485–94.
    1. Hägglund G, Wagner P Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord. 2008; 9:150. doi: 10.1186/1471-2474-9-150. - DOI - PMC - PubMed
    1. Graham HK, Aoki KR, Autti-Rämö I, et al.. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11(1)67–79. doi: 10.1016/s0966-6362(99)00054-5. - DOI - PubMed

Publication types